The use of MIDAS in patients with chronic migraine and medication-overuse headache: should we trust it?

Neurol Sci. 2018 Jun;39(Suppl 1):125-127. doi: 10.1007/s10072-018-3373-7.

Authors

Alberto Raggi¹, Licia Grazzi², Eleonora Grignani³, Matilde Leonardi³, Emanuela Sansone², Chiara Scaratti³, Domenico D'Amico²

Affiliations

¹ Neurology, Public Health and Disability Unit, Neurological Institute C. Besta, Via Celoria 11, 20133, Milan, Italy. alberto.raggi@istituto-besta.it.
² Headache and Neuroalgology Unit, Neurological Institute C. Besta, Milan, Italy.
³ Neurology, Public Health and Disability Unit, Neurological Institute C. Besta, Via Celoria 11, 20133, Milan, Italy.

PMID: 29904852
DOI: 10.1007/s10072-018-3373-7

No abstract available

MeSH terms

Adult
Chronic Disease
Disability Evaluation*
Female
Headache Disorders, Secondary / diagnosis*
Headache Disorders, Secondary / physiopathology*
Humans
Male
Middle Aged
Migraine Disorders / diagnosis*
Migraine Disorders / physiopathology*
Reproducibility of Results